TREA

79312182 - ELATIVE

Follow

Information

  • Trademark
  • 79312182
  • Serial Number
    79312182
  • Registration Number
    6681657
  • Filing Date
    January 20, 2021
    4 years ago
  • Registration Date
    March 29, 2022
    3 years ago
  • Transaction Date
    September 12, 2022
    2 years ago
  • Status Date
    March 29, 2022
    3 years ago
  • Published for Opposition Date
    January 11, 2022
    3 years ago
  • Location Date
    March 29, 2022
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    HUDSON, TAMARA BREE
  • Attorney Docket Number
    04774.T980US
    Attorney Name
    Brooks R. Bruneau
    Law Office Assigned Location Code
    L40
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
ELATIVE
Case File Statements
  • GS0051: Pharmaceutical preparations for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; chemical preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; organic preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; diagnostic preparations for medical use; diagnostic reagents for medical use
  • GS0421: Scientific research for medical purposes; pharmaceutical research and development services; conducting clinical trials for pharmaceutical products for others, in particular conducting clinical trials for determining the efficacy and safety of elafibranor; conducting clinical trials for others to determine the efficacy and safety of pharmaceutical products in the treatment of primary biliary cholangitis (PBC); conducting scientific studies and analyses in the field of pharmaceuticals and medicines; scientific research and development, namely, providing information, results and data relating to scientific or medical research and development of pharmaceutical products, via an online searchable database; conducting clinical trials for others; pharmaceutical and biological product development and research services for third parties; conducting clinical research for others; evaluation of the efficacy of pharmaceutical products; clinical product development services
Case File Event Statements
  • 9/12/2022 - 2 years ago
    28 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 8/23/2022 - 2 years ago
    27 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 8/23/2022 - 2 years ago
    26 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 6/29/2022 - 2 years ago
    25 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 5/8/2022 - 2 years ago
    24 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 3/29/2022 - 3 years ago
    23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/11/2022 - 3 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/11/2022 - 3 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/10/2022 - 3 years ago
    20 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 12/22/2021 - 3 years ago
    19 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 12/22/2021 - 3 years ago
    18 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 12/22/2021 - 3 years ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/9/2021 - 3 years ago
    16 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 12/9/2021 - 3 years ago
    15 - ASSIGNED TO LIE Type: ALIE
  • 12/8/2021 - 3 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/6/2021 - 3 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/6/2021 - 3 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/6/2021 - 3 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/11/2021 - 3 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 8/25/2021 - 3 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 8/25/2021 - 3 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 8/7/2021 - 3 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 8/6/2021 - 3 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/3/2021 - 3 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/12/2021 - 3 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 6/8/2021 - 3 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 6/7/2021 - 3 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 6/3/2021 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR